Currently out of the existing stock ratings of Kelly Shi, 17 are a BUY (94.44%), 1 are a HOLD (5.56%).

Kelly Shi

Work Performance Price Targets & Ratings Chart

Analyst Kelly Shi works at JEFFERIES with a stock forecast success ratio of 38.1% fulfilled within 166 days on average.

Kelly Shi’s has documented 36 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ACET, Adicet Bio at 05-Jan-2024.

Wall Street Analyst Kelly Shi

Analyst best performing recommendations are on MLTX (MOONLAKE IMMUNOTHERAPEUTICS).
The best stock recommendation documented was for MLTX (MOONLAKE IMMUNOTHERAPEUTICS) at 6/26/2023. The price target of $58 was fulfilled within 22 days with a profit of $12.05 (26.22%) receiving and performance score of 11.92.

Average potential price target upside

HGEN Humanigen IMGN ImmunoGen KYMR Kymera Therapeutics MLTX MoonLake Immunotherapeutics IBRX Immunitybio ACET Adicet Bio PTCT PTC Therapeutics

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

0.5

$0.5 (0.00%)

0.5

1 years 9 days ago

1/4 (25%)

$0.36 (257.14%)

2

Hold

0.15

$0.15 (0.00%)

2

1 years 3 months 1 days ago

1/4 (25%)

$-0.01 (-6.25%)

8

Buy

19

$18.86 (13471.43%)

19

2 years 3 months 9 days ago

0/5 (0%)

$14.39 (153.53%)

Sell

21

2 years 7 months 3 days ago

2/2 (100%)

$0.83 (4.65%)

18

Buy

30

$29.99 (299900.00%)

30

2 years 7 months 19 days ago

0/2 (0%)

$11.69 (64.34%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Kelly Shi is most bullish on?

Potential upside of $19.73 has been obtained for MLTX (MOONLAKE IMMUNOTHERAPEUTICS)

Which stock is Kelly Shi is most reserved on?

Potential downside of -$0.23 has been obtained for IMGN (IMMUNOGEN)

What Year was the first public recommendation made by Kelly Shi?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?